Viridian Therapeutics, Inc.DE - Common Stock (VRDN)
CUSIP: 92790C104
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 95,489,675
- Total 13F shares
- 13,600,109
- Share change
- +7,596,653
- Total reported value
- $223,717,000
- Price per share
- $16.45
- Number of holders
- 38
- Value change
- +$123,512,129
- Number of buys
- 32
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 92790C104?
CUSIP 92790C104 identifies VRDN - Viridian Therapeutics, Inc.DE - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92790C104:
Top shareholders of VRDN - Viridian Therapeutics, Inc.DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Public Fund, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,505,200
|
$31,609,200 | — | 23 Sep 2021 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.9%
|
859,910
|
$15,728,000 | — | 30 Jun 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.83%
|
794,506
|
$14,531,000 | — | 30 Jun 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.75%
|
720,373
|
$13,176,000 | — | 30 Jun 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.61%
|
578,560
|
$10,582,000 | — | 30 Jun 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.41%
|
395,534
|
$7,234,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.37%
|
354,066
|
$6,476,000 | — | 30 Jun 2021 | |
| BVF INC/IL |
13F
|
Company |
0.37%
|
350,081
|
$6,403,000 | — | 30 Jun 2021 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.37%
|
350,000
|
$6,402,000 | — | 30 Jun 2021 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.36%
|
342,962
|
$6,273,000 | — | 30 Jun 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.33%
|
312,328
|
$5,712,000 | — | 30 Jun 2021 | |
| Atlas Venture Advisors, Inc. |
13F
|
Company |
0.22%
|
209,505
|
$3,832,000 | — | 30 Jun 2021 | |
| Commodore Capital LP |
13F
|
Company |
0.2%
|
186,405
|
$3,409,000 | — | 30 Jun 2021 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.13%
|
119,478
|
$2,185,000 | — | 30 Jun 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.12%
|
117,715
|
$2,153,000 | — | 30 Jun 2021 | |
| BAILARD, INC. |
13F
|
Company |
0.09%
|
90,500
|
$1,655,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.05%
|
50,252
|
$919,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
38,283
|
$700,000 | — | 30 Jun 2021 | |
| Fairmount Funds Management LLC |
13F
|
Company |
0.04%
|
35,092
|
$642,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
31,467
|
$576,000 | — | 30 Jun 2021 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
28,399
|
$519,000 | — | 30 Jun 2021 | |
| VR Adviser, LLC |
13F
|
Company |
0.02%
|
19,495
|
$357,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.01%
|
11,041
|
$202,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
6,985
|
$128,000 | — | 30 Jun 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
519
|
$10,000 | — | 30 Jun 2021 |
Institutional Holders of Viridian Therapeutics, Inc.DE - Common Stock (VRDN) as of Q3 2021
As of 30 Sep 2021,
Viridian Therapeutics, Inc.DE - Common Stock (VRDN) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,600,109 shares.
The largest 10 holders included
FRAZIER MANAGEMENT LLC, Logos Global Management LP, PERCEPTIVE ADVISORS LLC, Vivo Capital, LLC, Fairmount Funds Management LLC, Ally Bridge Group (NY) LLC, BVF INC/IL, D. E. Shaw & Co., Inc., COMMODORE CAPITAL LP, and Point72 Asset Management, L.P..
This page lists
38
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
24
Q3 2021 holders
38
Holder diff
14
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.